Chugai Pharma Manufacturing Co., Ltd.

Form 483 issued September 26, 2019 · Utsunomiya, Japan

Inspection
Sep 17 – Sep 26, 2019
Investigator
Cheryl Clausen
Observations
4
Pages
6
FEI number
3006942691

In short: On September 26, 2019, FDA issued a Form 483 with 4 observations to Chugai Pharma Manufacturing Co., Ltd. in Utsunomiya, TCG (FEI 3006942691) after an inspection that ran Sep 17 – Sep 26, 2019. The investigator was Cheryl Clausen. Most observations concern laboratory controls and facilities & equipment.

At a glance

Observations span 4 systems, led by laboratory controls.

Laboratory controls1
Facilities & equipment1
Production1
Quality system1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Laboratory records do not include complete data derived from all tests, examinations and assay necessary to…

  2. 02

    Appropriate controls are not exercised over computers or related systems to assure that changes in master…

  3. 03

    Control procedures are not established which monitor the output of those manufacturing processes that may be…

  4. 04

    The quality control unit lacks authority to review production records to assure that no errors have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Chugai Pharma Manufacturing Co., Ltd.?

FDA listed 4 observations on this Form 483, mostly about laboratory controls, facilities & equipment and production. The opening words of each observation are shown on this page.

Who inspected Chugai Pharma Manufacturing Co., Ltd.?

Cheryl Clausen is named on this Form 483, for the inspection of Sep 17 – Sep 26, 2019. Each investigator has a profile showing what they cite most.

When was Chugai Pharma Manufacturing Co., Ltd. inspected by FDA?

The inspection ran Sep 17 – Sep 26, 2019, and the Form 483 is dated September 26, 2019.

How do I get the full Form 483 for Chugai Pharma Manufacturing Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free